IPP Bureau
Aster Pharmacy to provide free random Blood Sugar and Blood Pressure check-ups at all its pharmacy outlets
By IPP Bureau - July 03, 2024
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Aster Whitefield Hospital and government partner for free epilepsy camp in Kolar
By IPP Bureau - July 03, 2024
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID-19 prevention
By IPP Bureau - July 03, 2024
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Avallano appoints Michael A. Ibara as Chief Strategy Officer
By IPP Bureau - July 03, 2024
Ibara will drive AI-powered clinical research innovation
LG Chem enters Chinese osteoarthritis treatment market
By IPP Bureau - July 03, 2024
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Abbott and YRGCARE inaugurate new outreach centers in India
By IPP Bureau - July 02, 2024
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
By IPP Bureau - July 02, 2024
Imfinzi also recommended for patients with mismatch repair deficient disease
Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
By IPP Bureau - July 02, 2024
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
DKSH and Kimberly-Clark Partner to Launch Huggies Baby and Childcare Products in Cambodia
By IPP Bureau - July 02, 2024
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
Briefs: Family Care Hospitals, Laurus Labs and Bafna Pharmaceuticals
By IPP Bureau - June 30, 2024
Laurus Labs receives EIR from USFDA for API facilities
ONGC to enhance healthcare facilities at Baltal and Chandanwari in J&K
By IPP Bureau - June 30, 2024
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Orchid Pharma and Cipla collaborate to launch antibiotic Cefepime-Enmetazobactam in India
By IPP Bureau - June 29, 2024
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Alembic Pharmaceuticals announces USFDA final approval for Doxycycline Capsules, 40 mg
By IPP Bureau - June 29, 2024
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
HCG acquires 51% stake in Mahatma Gandhi Cancer Hospital and Research Institute, Vizag
By IPP Bureau - June 29, 2024
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
